16-3137675-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004220.3(ZNF213):c.395G>A(p.Arg132Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000583 in 1,613,230 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004220.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF213 | NM_004220.3 | c.395G>A | p.Arg132Gln | missense_variant | 2/6 | ENST00000396878.8 | NP_004211.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF213 | ENST00000396878.8 | c.395G>A | p.Arg132Gln | missense_variant | 2/6 | 1 | NM_004220.3 | ENSP00000380087.3 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152164Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000130 AC: 32AN: 245840Hom.: 0 AF XY: 0.000150 AC XY: 20AN XY: 133772
GnomAD4 exome AF: 0.0000575 AC: 84AN: 1460948Hom.: 0 Cov.: 31 AF XY: 0.0000550 AC XY: 40AN XY: 726792
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152282Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2023 | The c.395G>A (p.R132Q) alteration is located in exon 2 (coding exon 1) of the ZNF213 gene. This alteration results from a G to A substitution at nucleotide position 395, causing the arginine (R) at amino acid position 132 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at